Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-11-29 Purchase | 2021-12-01 11:06 am | Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. INTERIM CFO | 50,000 | $0.72 | $36,000 | 50,000 (Direct) | View |
| 2020-05-22 Purchase | 2020-05-27 9:36 pm | WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director | 2,069 | $7.25 | $15,000 | 4,138 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-17 Option Award | 2024-05-20 7:47 pm | N/A 2034-05-16 | CalciMedica Inc. | CALC | Geffken Daniel E. Interim CFO | 10,000 | $0 | 10,000 (Indirect) | View |
| 2024-02-14 Other | 2024-02-16 7:39 pm | N/A N/A | CERO THERAPEUTICS HOLDINGS INC. | CERO | Geffken Daniel E. Chief Financial Officer | 10,002 | $0 | 20,004 (Direct) | View |
| 2023-10-26 Option Award | 2023-10-30 7:42 pm | N/A 2033-10-26 | ProMIS Neurosciences Inc. | PMN | Geffken Daniel E. Chief Financial Officer | 2,500 | $0 | 2,500 (Direct) | View |
| 2023-08-23 Option Award | 2023-08-29 4:37 pm | N/A 2033-08-23 | WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director | 5,083 | $0 | 5,225 (Direct) | View |
| 2023-03-20 Option Award | 2023-05-03 8:59 pm | N/A 2030-11-09 | CalciMedica Inc. | CALC | Geffken Daniel E. Interim CFO | 17,280 | $0 | 17,280 (Indirect) | View |
Ownership | 2023-05-03 8:55 pm | N/A 2029-12-11 | CalciMedica Inc. | CALC | Geffken Daniel E. Interim CFO | 0 | $0 | 1,982 (Indirect) | View |
Ownership | 2022-07-07 7:28 pm | N/A N/A | ProMIS Neurosciences Inc. | PMN | Geffken Daniel E. Chief Financial Officer | 0 | $0 | 23,560 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-09 8:13 pm | 2023-06-07 2032-06-07 | WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director | 12,500 | $0 | 14,569 (Direct) | View |
| 2021-10-08 Other | 2021-10-12 7:35 pm | N/A N/A | PHOENIX BIOTECH ACQUISITION CORP. | PBAX | Geffken Daniel E. Chief Financial Officer | 30,000 | $0 | 30,000 (Indirect) | View |
| 2021-06-15 Option Award | 2021-06-17 8:02 pm | 2022-06-15 2031-06-15 | WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director | 15,000 | $0 | 17,069 (Direct) | View |
| 2021-04-20 Option Award | 2021-04-22 11:55 am | N/A 2026-04-20 | Eloxx Pharmaceuticals Inc. | ELOX | Geffken Daniel E. CHIEF FINANCIAL OFFICER | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-02-03 Option Award | 2021-02-05 9:11 pm | 2021-02-03 2031-02-03 | WINDTREE THERAPEUTICS INC | WINT | Geffken Daniel E. Director | 15,000 | $0 | 17,069 (Direct) | View |
| 2021-01-12 Other | 2021-01-14 7:49 pm | N/A N/A | Locust Walk Acquisition Corp. | LWAC | Geffken Daniel E. Chief Financial Officer | 20,000 | $0 | 20,000 (Indirect) | View |